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Introduction: Smoking/
Nicotine Withdrawal
• 25% of the US adult population continues to 
smoke (CDC, 2002).
• Over 50% of smokers report symptoms of 
nicotine withdrawal after they quit or cut-down 
(Breslau et al., 1992; Pergadia et al., 2006).
• Up to 47% of the variance in nicotine 
withdrawal can be accounted for by genetic 
factors (Pergadia et al., 2006).
Introduction: Alcohol Use Problems
• 19% of the US adult population has 
experienced an alcohol use disorder at some 
point in their life (Kessler et al., 2005).
• Up to 47% of the variance in alcohol 
dependence may be accounted for by genetic 
influences, even after controlling for 
demographics and co-morbid psychopathology 
(Knopik et al., 2004).
Introduction: Nicotine and 
Alcohol Use Problems
• Increasing levels of nicotine withdrawal severity are 
associated with increased risk of alcohol dependence (Breslau 
et al., 1992; Madden et al., 1997; Xian et al., 2004). 
• There is evidence for genetic overlap between nicotine 
dependence and alcohol dependence in men (Madden et al., 
Guze 2006; True et al., 1999), and for genetic overlap between 
history of smoking and alcohol intoxication, especially in 
women (Madden et al., 1997).
• Even after accounting for regular smoking, significant 
phenotypic (r = .15) and genetic overlap (rg = .26) is found 
between nicotine withdrawal and alcohol dependence, 
suggesting that some additional genetic factors might be 
accounting for the covariation at this later stage of smoking 
behavior (nicotine withdrawal; Pergadia et al., Guze 2006).
Candidate Genes for Nicotine Withdrawal
• Pharmacologic (Damaj et al., 2003) and genetic knock-out 
work in mice (Salas et al., 2004) implicate the importance of 
nicotinic acetylcholine alpha-3, alpha-5, beta-4 receptor gene 
cluster in nicotine withdrawal behavior.
• A recent genome-wide association study in humans (Saccone 
et al., 2007) found this cluster of genes to be highly 
associated with nicotine dependence.
• However, the extent to which the nicotinic acetylcholine 
alpha-3, alpha-5, beta-4 receptor genes are associated with 
nicotine withdrawal (or co-morbid nicotine withdrawal and 
alcohol dependence) remains to be studied in humans.
Aims
• To examine the genetic association 
between DSM-IV nicotine withdrawal 
and alcohol dependence and the nicotinic 
acetylcholine alpha-3, alpha-5, beta-4 
receptor genes using family data.
DSM-IV Nicotine Withdrawal (APA, 1994)
• Withdrawal, as manifested by either of the following:
1) 4 or more of the following:






• Decreased heart rate
• Increased appetite
2) Smoked cigarettes to relieve or avoid withdrawal 
symptoms.
DSM-IV Alcohol Dependence 
(APA, 1994)
Three or more of the following symptoms clustering in any 12 month period:
1) Tolerance
• Need more alcohol for intoxication effects, or
• Same amount of alcohol has less of an effect
2) Withdrawal
• Alcohol withdrawal syndrome, or
• Withdrawal relief: use alcohol to avoid or relieve symptoms
3) Use alcohol more than intended
4) Persistent desire or unsuccessful efforts to cut down on alcohol
5) Great deal of time spent obtaining, using or recovering from alcohol
6) Important social, occupational, or recreational activities given up or 
reduced because of alcohol use
7) Continued use despite knowledge or persistent or recurrent physical 
or psychological problems caused or made worse by alcohol 
Sample: Australian site of the Nicotine Addiction 
Genetics (NAG) project (PI: Madden)
• Nicotine gene-mapping project ascertained using an 
affected sib-pair design
• Over 400 families associated with the Australian twin 
registry, including spouse families, where proband is a 
heavy smoker: 20+ cigarettes per day, where  samples of 
DNA and phenotypic information is available (over 600 
ASP and over 450 parent-offspring trios)
• For this PDT association analyses (which included sibs 
concordant and discordant for hypothesized phenotypes): 
N=507 families, 1845 individuals, average sib-age: 42










Linkage Disequilibrium Plot: Nicotinic Acetylcholine Alpha-3, Alpha-5, Beta-4 Receptor Genes
D’: higher levels associated with darker red
r2: reported inside of diamonds
Preliminary Findings
• Preliminary results suggest an association between DSM-IV nicotine 
withdrawal and alcohol dependence and polymorphisms within two 
hypothesized candidate genes: CHRNA5 and CHRNA3. 
• For CHRNA3 the findings appear to be driven by nicotine withdrawal
– Within CHRNA3: rs11637630 and rs3743078 are in very high LD (r2= 
0.97), whereas they are in relatively lower LD with rs578776 (r2= 0.74 and 
r2= 0.75, respectively), suggesting that rs578776 is exerting some unique 
genetic influence nicotine withdrawal, whereas the genetic effects of 
rs11637630 and rs3743078 overlap. 
– Interesting, in Saccone et al. (2007) rs578776 ranked number three in 
terms of predicting nicotine dependence in a study over 348 candidate 
genes.
• One SNP within the CHRNA5, rs569207 was associated with both 
nicotine withdrawal and alcohol dependence, suggesting that it might 
be associated with a general genetic vulnerability to substance use 
behavior. 
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